MedTrace Logo

Effectiveness of Corticosteroid vs Ketorolac Shoulder Injections

NCT04895280 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2024-11-15

No results posted yet for this study

Summary

The purpose of this study is to compare the functional outcomes of patients with shoulder pathology treated with either ketorolac or corticosteroid injections, in a randomized double-blinded study. Investigators will compare the effectiveness of ketorolac compared to corticosteroid.

Specific Aim 1:

Hypothesis 1: Injection of the shoulder (in the subacromial space) with Ketorolac will be more effective than corticosteroid injection for the treatment of a variety of shoulder pathologies.

The risks associated with this study primarily concern adverse reactions to the study drugs. The drugs used in this study are not narcotics or habit-forming but can have side effects. The patient's physician will screen for any heart, intestinal, or kidney disease or condition that would increase the chance for the patient to have an unwanted side effect.

Conditions

  • Full-thickness Rotator Cuff Tear
  • Rotator Cuff Tendinitis

Interventions

DRUG

Ketorolac

Ketorolac: will receive an injection of 4 cc 0.25% Marcaine without epinephrine and 30 mg ketorolac x 1

DRUG

Marcaine

Marcaine (control): will receive an injection of 4 cc 0.25% Marcaine without epinephrine

DRUG

Kenalog

Kenalog: 4 cc 0.25% Marcaine without epinephrine and 40 mg triamcinolone x 1.

Sponsors & Collaborators

  • Michael Khazzam

    lead OTHER

Principal Investigators

  • Michael Khazzam, MD · 214-645-3300

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2026-11-30
Completion
2028-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04895280 on ClinicalTrials.gov